polynovo divests aod9604 AOD-9604 - Research-Grade Peptide | COA Verified AOD-9604 5mg | Research Peptide
Description
AOD-9604 has a short half-life of approximately 30 minutes, which means each injection creates a brief window of lipolytic activity rather than sustained fat mobilization
The daily approved amount of vitamin B12 is not anticipated to cause major fetal harm or miscarriage
AOD-9604 works by stimulating lipolysis and inhibiting lipogenesis in adipose tissue, effects traditionally attributed to the C-terminal region of growth hormone
It falls under the S0 category of Non-Approved Substances, which is a catch-all classification for any pharmacological substance that isnt approved for human therapeutic use and is not addressed elsewhere on the list
